The management of perimenopausal abnormal uterine bleeding
Abnormal uterine bleeding in the perimenopause is a common gynaecological disorder and may affect 20 –50 % of all women. It may be the first sign of premalignant or malignant disease. All women require assessment by means of pelvic ultrasound and an endometrial biopsy to exclude sinister pathology, identify other causes, and plan appropriate treatment. Pharmacological treatment includes antifibri nolytics, non-steroidal anti-inflammatories, combined hormonal contraception, cyclical progestogens and the levonorgestrel intrauterine system (LNG – IUS).
Source: Obstetrics, Gynaecology and Reproductive Medicine - Category: OBGYN Authors: Chloe Manley, Theofanis Manias Tags: Review Source Type: research
More News: Bleeding | Cancer & Oncology | Endometrial Biopsy | Hormones | Mirena | OBGYN | Pathology | Ultrasound | Women